Fredrik Hieronymus (F Hieronymus)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 25

Top Topics

Bipolar Disorder

Clinical Practice

Top Venues

Translational psychiatry

Acta psychiatrica Scandinavica

Acta neuropsychiatrica

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher Rohde, Fredrik Hieronymus, Søren Dinesen Østergaard
A target trial emulation comparing the antidepressant effectiveness of selective serotonin reuptake inhibitors (SSRIs) highlighting the importance of patent-related confounding by indication. Acta psychiatrica Scandinavica (2024)
Christopher Rohde, Fredrik Hieronymus, Søren Dinesen Østergaard
A target trial emulation comparing the antidepressant effectiveness of selective serotonin reuptake inhibitors (SSRIs) highlighting the importance of patent-related confounding by indication. Acta psychiatrica Scandinavica 150 (4) (2024)
Lynn Boschloo, Fredrik Hieronymus, Alexander Lisinski, Pim Cuijpers, Elias Eriksson
The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective. Translational psychiatry 13 (1) (2023)
Fredrik Hieronymus, Christoph Ulrich Correll, Søren Dinesen Østergaard
Initial severity of the Positive and Negative Syndrome Scale (PANSS)-30, its main subscales plus the PANSS-6, and the relationship to subsequent improvement and trial dropout: a pooled participant-level analysis of 18 placebo-controlled risperidone and paliperidone trials. Translational psychiatry 13 (1) (2023)
Lynn Boschloo, Fredrik Hieronymus, Alexander Lisinski, Pim Cuijpers, Elias Eriksson
The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective. Translational psychiatry 13 (1) (2023)
Lynn Boschloo, Fredrik Hieronymus, Alexander Lisinski, Pim Cuijpers, Elias Eriksson
The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective. Translational psychiatry 13 (1) (2023)
Lynn Boschloo, Fredrik Hieronymus, Alexander Lisinski, Pim Cuijpers, Elias Eriksson
The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective. Translational psychiatry 13 (1) (2023)
Lynn Boschloo, Fredrik Hieronymus, Alexander Lisinski, Pim Cuijpers, Elias Eriksson
The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective. Translational psychiatry 13 (1) (2023)
Rasmus Lorentzen, Tuan D Nguyen, Alexander McGirr, Fredrik Hieronymus, Søren Dinesen Østergaard
The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: a systematic review and meta-analysis. Schizophrenia (Heidelberg, Germany) 8 (1) (2022)
Alexander Lisinski, Fredrik Hieronymus, Staffan Nilsson, Elias Eriksson
Impact of chosen cutoff on response rate differences between selective serotonin reuptake inhibitors and placebo. Translational psychiatry 12 (1) (2022)
Fredrik Hieronymus, Alexander Lisinski, Magnus Hieronymus, Jakob Näslund, Elias Eriksson, Søren Dinesen Østergaard
Determining maximal achievable effect sizes of antidepressant therapies in placebo-controlled trials. Acta psychiatrica Scandinavica 144 (3) (2021)
Alexander Lisinski, Fredrik Hieronymus, Elias Eriksson, Susanna M Wallerstedt
Low SSRI dosing in clinical practice-a register-based longitudinal study. Acta psychiatrica Scandinavica 143 (5) (2021)
Fredrik Hieronymus, M Hieronymus, S Nilsson, Elias Eriksson, Søren Dinesen Østergaard
Individual variability in treatment response to antidepressants in major depression: comparing trial-level and patient-level analyses. Acta psychiatrica Scandinavica 142 (6) (2021)
Fredrik Hieronymus, Pernille Kølbæk, Christoph U Correll, Søren D Østergaard
Antipsychotic-placebo separation on the PANSS-6 subscale as compared to the PANSS-30: a pooled participant-level analysis. NPJ schizophrenia 7 (1) (2021)
Fredrik Hieronymus, Alexander Lisinski, Elias Eriksson, Søren Dinesen Østergaard
Do side effects of antidepressants impact efficacy estimates based on the Hamilton Depression Rating Scale? A pooled patient-level analysis. Translational psychiatry 11 (1) (2021)
Fredrik Hieronymus, Alexander Lisinski, Elias Eriksson, Søren Dinesen Østergaard
Correction: Do side effects of antidepressants impact efficacy estimates based on the Hamilton Depression Rating Scale? A pooled patient-level analysis. Translational psychiatry 11 (1) (2021)
Michael Moesmann Madsen, David Dines, Fredrik Hieronymus
Optimizing psychiatric care during the COVID-19 pandemic. Acta psychiatrica Scandinavica 142 (1) (2020)
Fredrik Hieronymus, Sameer Jauhar, Søren Dinesen Østergaard, Allan H Young
One (effect) size does not fit at all: Interpreting clinical significance and effect sizes in depression treatment trials. Journal of psychopharmacology (Oxford, England) 34 (10) (2020)
Alexander Lisinski, Fredrik Hieronymus, Jakob Näslund, Staffan Nilsson, Elias Eriksson
Item-based analysis of the effects of duloxetine in depression: a patient-level post hoc study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 45 (3) (2019)
Fredrik Hieronymus, Alexander Lisinski, Jakob Näslund, Elias Eriksson
Good news regarding SSRI safety in Danish meta-analysis. Acta neuropsychiatrica 32 (1) (2019)
Fredrik Hieronymus, Alexander Lisinski, Jakob Näslund, Elias Eriksson
Katakam and co-workers have not shown SSRIs to be harmful and ineffective and should stop claiming that they have. Acta neuropsychiatrica 30 (5) (2018)
Jakob Näslund, Fredrik Hieronymus, J F Emilsson, A Lisinski, Staffan Nilsson, Elias Eriksson
Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression. Acta psychiatrica Scandinavica 136 (4) (2017)
Fredrik Hieronymus, Alexander Lisinski, Jakob Näslund, Elias Eriksson
Multiple possible inaccuracies cast doubt on a recent report suggesting selective serotonin reuptake inhibitors to be toxic and ineffective. Acta neuropsychiatrica 30 (5) (2017)
Fredrik Hieronymus, S Nilsson, E Eriksson
A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors. Translational psychiatry 6 (6) (2016)
Fredrik Hieronymus, J F Emilsson, S Nilsson, E Eriksson
Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Molecular psychiatry 21 (4) (2015)